Source: StreetInsider

C. R. Bard: AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system,...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more